Industry

The company will unveil Dexcom Smart Basal*, a new integrated titration module designed to make basal insulin initiation and management easier† for users, which is currently under FDA and CE mark review. New Dexcom CGM data revealed at the conference will demonstrate how exercise before versus after meals can optimize glucose excursions in pregnant women … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that Frédéric Lombard, Chief financial Officer of the Company, will participate in the 25th edition of the European Midcap Event being held from September 30 to October 1, 2025 in Paris, France. The European Midcap Event is … [Read more…]

PHOENIX–(BUSINESS WIRE)–Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market. FABRX, founded over a decade ago, has successfully deployed pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Pete Pharma will leverage this deep foundation … [Read more…]

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 8,744 shares of Evolus common stock and an aggregate of 15,000 restricted stock units (RSUs) of the company’s common stock … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Medra, a startup building “Physical AI for experimentation,” today announced the launch of its Continuous Science Platform, a first-of-its-kind system that integrates robotics and AI to accelerate scientific data generation and discovery. Medra’s vision is grounded in a simple belief: if AI will one day help eradicate disease, science must first overcome the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Anxiety Disorders and Depression Treatment Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The size of the Anxiety Disorders and Depression Treatment Market stood at USD 20.51 billion in 2024 and is anticipated to be USD 34.31 billion by 2033, at a … [Read more…]

HANGZHOU, China–(BUSINESS WIRE)–At the 2025 INCLUSION · Conference on the Bund in Shanghai, Ant Group’s AI-powered healthcare app AQ has rolled out a new suite of service updates aimed at making healthcare more inclusive and accessible. “We hope AI can empower doctors by extending their reach to more patients, freeing up time for medical research … [Read more…]

MISHAWAKA, Ind.–(BUSINESS WIRE)–Intrepid Phoenix Ventures, Inc., an Indiana-based corporation headquartered in Mishawaka, is pleased to announce it has been awarded a Department of Defense (DoD) SBIR Phase I Grant through the Chief Digital and Artificial Intelligence Office (CDAO). The grant supports a pioneering research and development initiative titled: “Generative AI for Addiction Recovery: Enhancing Personalized … [Read more…]

BESSINES-SUR-GARTEMPE, France–(BUSINESS WIRE)–Orano Med: ATEF (Advanced Thorium Extraction Facility) plant is now watertight, marking a major step toward the completion of civil engineering work. Construction is progressing according to schedule, with start-up planned for 2027. A site visit brought together institutional partners, local authorities, and economic stakeholders to celebrate this achievement. ATEF will be the … [Read more…]

MATAWAN, N.J.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) today welcomed the U.S. Food and Drug Administration’s (FDA) newly released draft guidance on the development of non-opioid pain therapies, highlighting its potential to accelerate the company’s lead program, Apitox, for chronic osteoarthritis pain. The draft guidance, entitled “Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance … [Read more…]